To read the full article sign up for free or sign in.

Sight Diagnostics envisions expansion of disease detection with $71M series D funding

Aug. 10, 2020

Sight Diagnostics Ltd. raised $71 million in series D financing to expand its commercial operations and increase research and development efforts into disease detection from its fingerprick blood analyzer Sight OLO.

BioWorld MedTech Financings Artificial intelligence Coronavirus Series D Diagnostics Digital health Middle East North Africa

Today's news in brief

BioWorld

BioWorld briefs for May 9, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for May 9, 2025.

US flag, stock market chart, White House

100 days of uncertainty

BioWorld

The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the...

AI generated, 3D rendering of protein degradation

AACR 2025: Induced proximity strategy, beyond degraders

BioWorld

Targeted protein degradation has yet to notch its first approval. But with more than two dozen agents now in clinical trials, the strategy’s ultimate clinical...

NME Digest: Q1 2025

BioWorld

A quarterly dynamic table featuring new molecular entities (NMEs) revealed for the first time in current literature, at congresses and in company communications...